Castle Biosciences, Inc. (CSTL) stock analysis

CSTL · Castle Biosciences, Inc.

Latest recorded price: USD 32.75

Sector and industry: Healthcare · Diagnostics & Research

Fiscal 2025 figures: revenue growth 35.9%, free cash flow margin 8.2%, ROIC -16.6%. The model flags 1 risk signal for this company.

Similar companies in Healthcare